Description
A 5-HT1B receptor agonist (IC50 = 51 nM); selective for 5-HT1B over 5-HT1A and 5-HT2 receptors (IC50s = 876 and 6,480 nM, respectively), as well as α1-, α2-, and β-adrenergic and dopamine D1 and D2 receptors (IC50s = >6,000, >1,000, >1,000, >5,000, and >5,000 nM, respectively); inhibits forskolin-induced cAMP accumulation in opossum kidney cells from 0.001-1 µM; reduces 5-HTP accumulaiton in the the fronto-parietal cortex (ED50 = 7.92 µmol/kg) and induces dorsal raphe cell firing in rats (ED50 = 358 nmol/kg); decreases interfemale and intermale aggression in Syrian hamsters
Formal name: 4-(4-methyl-1-piperazinyl)-7-(trifluoromethyl)-pyrrolo[1,2-a]quinoxaline, (2Z)-2-butenedioate
Synonyms:
Molecular weight: 566.5
CAS: 109028-10-6
Purity: ≥98%
Formulation: A solid